RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients

The role of innate T cell subsets in the pathogenesis of spondyloarthritis (SpA) is not well understood. Here, the authors examine the role of invariant natural killer T (iNKT) and γδ-T cells in SpA and show that disease-derived iNKT and γδ-T cells have unique and Th17-skewed phenotype and gene expr...

Full description

Bibliographic Details
Main Authors: Koen Venken, Peggy Jacques, Céline Mortier, Mark E. Labadia, Tine Decruy, Julie Coudenys, Kathleen Hoyt, Anita L. Wayne, Robert Hughes, Michael Turner, Sofie Van Gassen, Liesbet Martens, Dustin Smith, Christian Harcken, Joseph Wahle, Chao-Ting Wang, Eveline Verheugen, Nadia Schryvers, Gaëlle Varkas, Heleen Cypers, Ruth Wittoek, Yves Piette, Lieve Gyselbrecht, Serge Van Calenbergh, Filip Van den Bosch, Yvan Saeys, Gerald Nabozny, Dirk Elewaut
Format: Article
Language:English
Published: Nature Portfolio 2019-01-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-018-07911-6
_version_ 1819202350025277440
author Koen Venken
Peggy Jacques
Céline Mortier
Mark E. Labadia
Tine Decruy
Julie Coudenys
Kathleen Hoyt
Anita L. Wayne
Robert Hughes
Michael Turner
Sofie Van Gassen
Liesbet Martens
Dustin Smith
Christian Harcken
Joseph Wahle
Chao-Ting Wang
Eveline Verheugen
Nadia Schryvers
Gaëlle Varkas
Heleen Cypers
Ruth Wittoek
Yves Piette
Lieve Gyselbrecht
Serge Van Calenbergh
Filip Van den Bosch
Yvan Saeys
Gerald Nabozny
Dirk Elewaut
author_facet Koen Venken
Peggy Jacques
Céline Mortier
Mark E. Labadia
Tine Decruy
Julie Coudenys
Kathleen Hoyt
Anita L. Wayne
Robert Hughes
Michael Turner
Sofie Van Gassen
Liesbet Martens
Dustin Smith
Christian Harcken
Joseph Wahle
Chao-Ting Wang
Eveline Verheugen
Nadia Schryvers
Gaëlle Varkas
Heleen Cypers
Ruth Wittoek
Yves Piette
Lieve Gyselbrecht
Serge Van Calenbergh
Filip Van den Bosch
Yvan Saeys
Gerald Nabozny
Dirk Elewaut
author_sort Koen Venken
collection DOAJ
description The role of innate T cell subsets in the pathogenesis of spondyloarthritis (SpA) is not well understood. Here, the authors examine the role of invariant natural killer T (iNKT) and γδ-T cells in SpA and show that disease-derived iNKT and γδ-T cells have unique and Th17-skewed phenotype and gene expression profiles within inflamed joints.
first_indexed 2024-12-23T04:02:37Z
format Article
id doaj.art-ddd72678135941fdb84362715749b1f1
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-23T04:02:37Z
publishDate 2019-01-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-ddd72678135941fdb84362715749b1f12022-12-21T18:00:42ZengNature PortfolioNature Communications2041-17232019-01-0110111510.1038/s41467-018-07911-6RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patientsKoen Venken0Peggy Jacques1Céline Mortier2Mark E. Labadia3Tine Decruy4Julie Coudenys5Kathleen Hoyt6Anita L. Wayne7Robert Hughes8Michael Turner9Sofie Van Gassen10Liesbet Martens11Dustin Smith12Christian Harcken13Joseph Wahle14Chao-Ting Wang15Eveline Verheugen16Nadia Schryvers17Gaëlle Varkas18Heleen Cypers19Ruth Wittoek20Yves Piette21Lieve Gyselbrecht22Serge Van Calenbergh23Filip Van den Bosch24Yvan Saeys25Gerald Nabozny26Dirk Elewaut27Department of Rheumatology, Faculty of Medicine and Health Sciences, Laboratory for Molecular Immunology and Inflammation, Ghent UniversityDepartment of Rheumatology, Faculty of Medicine and Health Sciences, Laboratory for Molecular Immunology and Inflammation, Ghent UniversityDepartment of Rheumatology, Faculty of Medicine and Health Sciences, Laboratory for Molecular Immunology and Inflammation, Ghent UniversityResearch and Development Boehringer-IngelheimDepartment of Rheumatology, Faculty of Medicine and Health Sciences, Laboratory for Molecular Immunology and Inflammation, Ghent UniversityDepartment of Rheumatology, Faculty of Medicine and Health Sciences, Laboratory for Molecular Immunology and Inflammation, Ghent UniversityResearch and Development Boehringer-IngelheimResearch and Development Boehringer-IngelheimResearch and Development Boehringer-IngelheimResearch and Development Boehringer-IngelheimVIB Inflammation Research Center, Ghent UniversityVIB Inflammation Research Center, Ghent UniversityResearch and Development Boehringer-IngelheimResearch and Development Boehringer-IngelheimResearch and Development Boehringer-IngelheimResearch and Development Boehringer-IngelheimDepartment of Rheumatology, Faculty of Medicine and Health Sciences, Laboratory for Molecular Immunology and Inflammation, Ghent UniversityDepartment of Rheumatology, Faculty of Medicine and Health Sciences, Laboratory for Molecular Immunology and Inflammation, Ghent UniversityDepartment of Rheumatology, Faculty of Medicine and Health Sciences, Laboratory for Molecular Immunology and Inflammation, Ghent UniversityDepartment of Rheumatology, Faculty of Medicine and Health Sciences, Laboratory for Molecular Immunology and Inflammation, Ghent UniversityDepartment of Rheumatology, Faculty of Medicine and Health Sciences, Laboratory for Molecular Immunology and Inflammation, Ghent UniversityDepartment of Rheumatology, Faculty of Medicine and Health Sciences, Laboratory for Molecular Immunology and Inflammation, Ghent UniversityASZ AalstLaboratory for Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Ghent UniversityDepartment of Rheumatology, Faculty of Medicine and Health Sciences, Laboratory for Molecular Immunology and Inflammation, Ghent UniversityVIB Inflammation Research Center, Ghent UniversityResearch and Development Boehringer-IngelheimDepartment of Rheumatology, Faculty of Medicine and Health Sciences, Laboratory for Molecular Immunology and Inflammation, Ghent UniversityThe role of innate T cell subsets in the pathogenesis of spondyloarthritis (SpA) is not well understood. Here, the authors examine the role of invariant natural killer T (iNKT) and γδ-T cells in SpA and show that disease-derived iNKT and γδ-T cells have unique and Th17-skewed phenotype and gene expression profiles within inflamed joints.https://doi.org/10.1038/s41467-018-07911-6
spellingShingle Koen Venken
Peggy Jacques
Céline Mortier
Mark E. Labadia
Tine Decruy
Julie Coudenys
Kathleen Hoyt
Anita L. Wayne
Robert Hughes
Michael Turner
Sofie Van Gassen
Liesbet Martens
Dustin Smith
Christian Harcken
Joseph Wahle
Chao-Ting Wang
Eveline Verheugen
Nadia Schryvers
Gaëlle Varkas
Heleen Cypers
Ruth Wittoek
Yves Piette
Lieve Gyselbrecht
Serge Van Calenbergh
Filip Van den Bosch
Yvan Saeys
Gerald Nabozny
Dirk Elewaut
RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients
Nature Communications
title RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients
title_full RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients
title_fullStr RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients
title_full_unstemmed RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients
title_short RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients
title_sort rorγt inhibition selectively targets il 17 producing inkt and γδ t cells enriched in spondyloarthritis patients
url https://doi.org/10.1038/s41467-018-07911-6
work_keys_str_mv AT koenvenken rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT peggyjacques rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT celinemortier rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT markelabadia rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT tinedecruy rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT juliecoudenys rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT kathleenhoyt rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT anitalwayne rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT roberthughes rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT michaelturner rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT sofievangassen rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT liesbetmartens rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT dustinsmith rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT christianharcken rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT josephwahle rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT chaotingwang rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT evelineverheugen rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT nadiaschryvers rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT gaellevarkas rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT heleencypers rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT ruthwittoek rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT yvespiette rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT lievegyselbrecht rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT sergevancalenbergh rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT filipvandenbosch rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT yvansaeys rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT geraldnabozny rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients
AT dirkelewaut rorgtinhibitionselectivelytargetsil17producinginktandgdtcellsenrichedinspondyloarthritispatients